Dr Reddy's Labs appoints Dr Alpna Hansraj Seth as Independent Additional Director Ruchika Sharma20 Sept 2023 12:38 PM ISTTelangana: Dr Reddy's Labs has announced the appointment of Dr. Alpna Hansraj Seth as an Additional Director, categorized as Independent, on the Board...
Cipla Buyout Battle: Dr Reddys, Bain Capital to team up for joint bid? Drugmaker issues statement Farhat Nasim6 Sept 2023 3:36 PM ISTNew Delhi: The buyout battle for 33.47 percent promoter stake in Cipla, owned by the Hamied family has intensified as US-based private equity...
Dr Reddy's Labs unveils Saxagliptin, Metformin Hydrochloride ER Tablets in US Ruchika Sharma11 Aug 2023 12:30 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S....
Dr Reddy's Labs gets USFDA EIR for Hyderabad facility Ruchika Sharma5 Aug 2023 1:30 PM ISTHyderabad: Dr Reddy's labs has announced that the Company has received the Establishment Inspection Report (EIR) from the United States Food and Drug...
Counterfeit medicines worth Rs 2 crore of Augmentin, Pan-D, Urimax-D and others seized from Kolkata warehouse Ruchika Sharma4 Aug 2023 2:30 PM IST"During the raid, counterfeit medicines, worth about Rs 2 crore of leading manufacturers such as Sun Pharmaceutical, Alkem, Cipla, Glenmark, GSK,...
USFDA concludes inspection at Dr Reddy's Labs Srikakulam facility with zero observations Ruchika Sharma20 July 2023 11:30 AM ISTThe inspection closed with zero observations and a classification of No Action Indicated.
Dr Reddy's Labs executes security subscription, shareholders' agreement with TEQ Green Power XI Private Limited, its affiliates Ruchika Sharma17 July 2023 12:30 PM ISTTelangana: Dr. Reddy’s Laboratories Limited has announced that the Company has entered into a Security Subscription and Shareholders’ Agreement for...
Global spending on COVID 19 expected to touch USD 500 billion by 2027: Dr Reddy's Labs Ruchika Sharma13 July 2023 3:15 PM ISTNew Delhi: Though the World Health Organisation lifted the emergency tag on COVID-19, global spending on the disease, including research to improve...
Dr Reddy's Labs proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA Ruchika Sharma13 July 2023 12:02 PM ISTDRL_RI is being developed as a biosimilar of Rituxan / MabThera (rituximab), a cluster of differentiation 20 (CD20) directed cytolytic antibody.
Dr Reddy's Labs selects Amazon Web Services as preferred cloud provider Ruchika Sharma11 July 2023 12:30 PM ISTNew Delhi: Amazon Web Services (AWS) on Monday announced that Dr. Reddy’s Laboratories has selected it as preferred cloud provider to help...
Dr Reddys Labs step down arm to establish bio-manufacturing facility in Hyderabad Ruchika Sharma5 July 2023 3:30 PM ISTThe company envisions significant scaling-up their investments in the future, which would result in a multi-fold increase in employment prospects in...
Dr Reddy's Labs forays into trade generics business in India with launch of new division Ruchika Sharma24 Jun 2023 2:31 PM ISTHyderabad: Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced its entry into the trade generics business in India with the...
